Dianthus Therapeutics, Inc. (DNTH) Operating income 2016–2025
Dianthus Therapeutics, Inc. (DNTH) annual operating income history from SEC filings — each fiscal year as reported.
-$177.9MFY2025 · since FY2016: -$9.3M → -$177.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$177.9M | -74.7% |
| FY2024 | -$101.9M | -111.5% |
| FY2023 | -$48.2M | -62.2% |
| FY2022 | -$29.7M | -127.0% |
| FY2021 | -$13.1M | +83.4% |
| FY2020 | -$78.7M | +5.1% |
| FY2019 | -$83.0M | -38.4% |
| FY2018 | -$60.0M | -67.8% |
| FY2017 | -$35.7M | -285.5% |
| FY2016 | -$9.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice